JLJani Liimatta

Jani Liimatta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jani Liimatta has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Increased levels of long-chain acylcarnitines and polyunsaturated fatty acids in girls with premature adrenarche: An exploratory longitudinal metabolomics study

    by Jani Liimatta, Therina du Toit, Iman Zarei, Retu Haikonen, Tuomas Selander, Marko Lehtonen, Seppo Auriola, Jean-Marc Nuoffer, Anders Juul, Timo A. Lakka, et al.

  • Open Access

    Circulating miR-1-3p precedes adrenarche and modulates adrenocortical steroidogenesis via protein kinase C signaling

    by Jani Liimatta, Emre Murat Altinkilic, Therina du Toit, Emma Raitoharju, Philipp Augsburger, Clarissa D Vögel, Aurel Perren, Jarmo Jääskeläinen, Timo A Lakka, Christa E Flück

    Context: Adrenarche involves maturation of the adrenal zona reticularis (ZR), but its molecular regulation is poorly understood. MicroRNAs (miRNAs) may contribute to adrenal development. Objective: To investigate whether circulating miRNAs are associated with ZR maturation during adrenarche and to characterize the functional role of candidate miRNAs in adrenal steroidogenesis. Design and setting: Prospective cohort study was nested within the population-based PANIC study with longitudinal follow-up at ages 7, 9, and 15 years, combined with experimental analyses in the human adrenocortical NCI-H295R cell model. Participants: A total of 34 children (20 girls) with clinical and/or biochemical signs of adrenarche at age 9 as cases, and 24 age-matched controls (11 girls). Interventions: None. Main outcome measures: Longitudinal serum miRNA expression and in vitro effects of candidate miRNAs on adrenal steroidogenesis and gene expression. Results: Serum miR-1-3p levels were higher in cases compared to controls at age 7 years (fold change 2, P < .001), preceding clinical adrenarche. In both groups, miR-1-3p levels declined during adrenarchal and pubertal development. In vitro, miR-1-3p overexpression increased steroidogenic activity (approximately 1.5-fold on average) without altering the expression of canonical steroidogenic enzyme genes. Transcriptomic analysis identified 208 upregulated and 140 downregulated genes, including PRKCA, encoding protein kinase C (PKC), enriched in the ZR and involved in steroidogenic signaling. Conclusion: Elevated circulating miR-1-3p precedes clinical adrenarche and enhances steroidogenesis in vitro. The temporal decline of circulating miR-1-3p levels and the identification of PKC support a model in which miR-1-3p may contribute to functional maturation of the ZR through modulation of noncanonical intracellular signaling pathways.


  • Open Access

    Serum and hair steroid profiles and their associations with body composition in adolescence

    by Jani Liimatta, Johanna Huotari, Therina du Toit, Christa E Flück, Jarmo Jääskeläinen, Anthony C Hackney, Merja R Häkkinen, Marko Lehtonen, Seppo Auriola, Timo A Lakka, et al.

    Objective: Accurate assessment of steroid hormones is essential for understanding sexual development and metabolic health. Blood-based steroid assays are informative but invasive and reflect only short-term fluctuations. We compared serum and hair steroid hormone profiles in adolescents and examined their associations with body size and composition, with attention to sex-specific patterns. Design: Cross-sectional analyses in a population-based sample of adolescents attending the 8-year follow-up examinations of the PANIC study in the city of Kuopio, Finland. Methods: The analyses included 241 late- or post-pubertal adolescents aged 15 to 16 years (103 girls, 137 boys). The participants underwent detailed clinical assessments, including anthropometry and dual-energy X-ray absorptiometry. Paired serum and scalp hair samples were collected and analyzed using liquid chromatography–mass spectrometry to quantify progestagens, androgens, 11-oxy androgens, mineralocorticoids, and glucocorticoids. Results: A broad spectrum of steroids was reliably detected in both serum and hair. Hair samples revealed distinct profiles characterized by pronounced accumulation of pregnenolone and measurable levels of cortisone, cortisol, dehydroepiandrosterone, androstenedione, androstanedione, 11β-hydroxyandrostenedione, 11-ketoandrostenedione, testosterone, and dihydrotestosterone, indicating active peripheral metabolism. Importantly, androgen levels in both serum and hair correlated more strongly with body size and composition in boys than in girls, suggesting sex-specific regulation of metabolic processes. Conclusions: Hair steroid profiling represents a feasible, non-invasive alternative to serum analysis, capturing both systemic hormone levels and localized metabolic activity. This approach shows considerable promise for clinical endocrinology; however, further validation across developmental stages and diverse disease contexts is necessary before it can be adopted into clinical practice. Clinical trials registration: The PANIC study has been registered at www.clinicaltrials.gov (No. NCT01803776).


  • Open Access

    Predicted Adult Height Remained Normal in Children With Premature Adrenarche Despite Advanced Bone Age

    by Eetu Kanniainen, Jarmo Jääskeläinen, Jani Liimatta

    Aim: Aetiological factors affecting the phenotype of adrenarche are largely unknown. This study investigated the phenotypic variability of premature adrenarche. Methods: In this cross‐sectional retrospective registry study, data on 91 mainly Caucasian children diagnosed with premature adrenarche were retrieved from patient records. Hormonal and growth‐related variables were analysed, and the data were further divided into subgroups to explore variations in different phenotypes of premature adrenarche. Results: We studied 91 children with premature adrenarche (23% boys) with median ages of 7.5 years (range 4.5–8.9) for boys and 6.8 years (4.3–8.0) for girls. They displayed increased height and weight, elevated androgen levels, and clinical signs of androgen action. Bone age was advanced by approximately 1 year, with overweight children showing more advanced bone age and linear growth. Adult heights predicted with bone age were comparable to mean parental heights. Girls with more advanced bone age had higher dehydroepiandrosterone sulfate (DHEAS) levels. Interestingly, early (< 6 years) diagnosed children exhibited higher height standard deviation scores but lower DHEAS levels compared to those diagnosed later (≥ 6 years). Conclusions: Despite advanced bone age, predicted adult heights remained normal in premature adrenarche. Subgroup differences suggested the heterogeneity of aetiological factors in premature adrenarche.


  • Open Access

    Ambiguous Genitalia Due to 3β-Hydroxysteroid Dehydrogenase Type 2 Deficiency: Clinical, Genetic, and Functional Characterization of Two Novel HSD3B2 Variants

    by Jani Liimatta, Kay Sauter, Therina du Toit, André Schaller, Dagmar L’aLlemand, Christa E Flück

    3β-Hydroxysteroid dehydrogenase 2 deficiency (3βHSD2D) is a rare form of congenital adrenal hyperplasia (CAH) with variable clinical presentation. We describe a 46, XY child with ambiguous genitalia and CAH without apparent adrenal insufficiency due to 2 novel heterozygous variants in the HSD3B2 gene (c.779C > T/p.Pro260Leu and c.307 + 1G > A/p.Gly103Asp,fs29X). The disease-causing effect of the novel variants was assessed by genetic and functional studies informing on positive genotype-phenotype correlation. Sex registration was female, and no gender dysphoria has been noted until the present age of 7 years, but psychological assessments have been difficult with a concomitant diagnosis of autism spectrum disorder. Virilization that already progresses prepubertally through peripheral conversion of androgen precursors by 3β-hydroxysteroid dehydrogenase 1 will pose an increasing challenge during puberty.


  • Open Access

    Multiple androgen pathways contribute to the steroid signature of adrenarche

    by Jani Liimatta, Therina du Toit, Clarissa D. Voegel, Jarmo Jääskeläinen, Timo A. Lakka, Christa E. Flück


  • Open Access

    Accelerated Early Childhood Growth Is Associated With the Development of Earlier Adrenarche and Puberty

    by Jani Liimatta, Jarmo Jääskeläinen, Aino Mäntyselkä, Merja R Häkkinen, Seppo Auriola, Raimo Voutilainen, Christa E Flück, Timo A Lakka

    Context: Small birth size and increased postnatal growth have been associated with earlier timing of adrenarche and puberty, but it is not well known whether these factors alone or together lead to earlier maturation. Objective: This work aimed to search for different growth trajectories using a clustering approach to analyze the effects of birth size and postnatal growth on adrenarchal and pubertal development. Methods: Altogether 351 children (48% girls) were examined prospectively at ages 6 to 9 and 9 to 11 years. Birth and early-growth data were collected retrospectively. Main outcome measures included clinical signs of adrenarche and puberty, and serum androgen concentrations (dehydroepiandrosterone, dehydroepiandrosterone sulfate, androstenedione, testosterone). Results: We detected 4 clusters with different birth sizes and postnatal growth trajectories: 1) children with average birth size and increased postnatal growth (AI), 2) children with small birth size and increased postnatal growth (SI), 3) children with average birth size and postnatal growth (AA), and 4) children with small birth size and average postnatal growth (SA). Thelarche at age 9 to 11 was most common and serum androgens at ages 6 to 9 and 9 to 11 years were highest in girls belonging to the AI and SI groups. Similar patterns in the onset of puberty and in androgen levels were not seen in the SA group. Conclusion: Increased early growth and weight gain predict higher serum androgen concentrations and earlier onset of puberty in girls. Adrenarche and puberty do not appear to be shifted earlier in children with small birth size who do not have catch-up growth.


  • Open Access

    Adrenal Abcg1 Controls Cholesterol Flux and Steroidogenesis

    by Jani Liimatta, Evelyn Curschellas, Emre Murat Altinkilic, Rawda Naamneh Elzenaty, Philipp Augsburger, Therina du Toit, Clarissa D Voegel, David T Breault, Christa E Flück, Emanuele Pignatti

    Cholesterol is the precursor of all steroids, but how cholesterol flux is controlled in steroidogenic tissues is poorly understood. The cholesterol exporter ABCG1 is an essential component of the reverse cholesterol pathway and its global inactivation results in neutral lipid redistribution to tissue macrophages. The function of ABCG1 in steroidogenic tissues, however, has not been explored. To model this, we inactivated Abcg1 in the mouse adrenal cortex, which led to an adrenal-specific increase in transcripts involved in cholesterol uptake and de novo synthesis. Abcg1 inactivation did not affect adrenal cholesterol content, zonation, or serum lipid profile. Instead, we observed a moderate increase in corticosterone production that was not recapitulated by the inactivation of the functionally similar cholesterol exporter Abca1. Altogether, our data imply that Abcg1 controls cholesterol uptake and biosynthesis and regulates glucocorticoid production in the adrenal cortex, introducing the possibility that ABCG1 variants may account for physiological or subclinical variation in stress response.


  • Top Cited Papers

    Update on Adrenarche—Still a Mystery

    by Philipp Augsburger, Philipp Augsburger, Jani Liimatta, Jani Liimatta, Christa E Flück, Christa E Flück

    Context Adrenarche marks the timepoint of human adrenal development when the cortex starts secreting androgens in increasing amounts, in healthy children at age 8–9 years, with premature adrenarche (PA) earlier. Because the molecular regulation and significance of adrenarche are unknown, this prepubertal event is characterized descriptively, and PA is a diagnosis by exclusion with unclear long-term consequences. Evidence Acquisition We searched the literature of the past 5 years, including original articles, reviews, and meta-analyses from PubMed, ScienceDirect, Web of Science, Embase, and Scopus, using search terms adrenarche, pubarche, DHEAS, steroidogenesis, adrenal, and zona reticularis. Evidence Synthesis Numerous studies addressed different topics of adrenarche and PA. Although basic studies on human adrenal development, zonation, and zona reticularis function enhanced our knowledge, the exact mechanism leading to adrenarche remains unsolved. Many regulators seem involved. A promising marker of adrenarche (11-ketotestosterone) was found in the 11-oxy androgen pathway. By current definition, the prevalence of PA can be as high as 9% to 23% in girls and 2% to 10% in boys, but only a subset of these children might face related adverse health outcomes. Conclusion New criteria for defining adrenarche and PA are needed to identify children at risk for later disease and to spare children with a normal variation. Further research is therefore required to understand adrenarche. Prospective, long-term studies should characterize prenatal or early postnatal developmental pathways that modulate trajectories of birth size, early postnatal growth, childhood overweight/obesity, adrenarche and puberty onset, and lead to abnormal sexual maturation, fertility, and other adverse outcomes.